Dr. Suthep Wongpat Dr. Suthep Wongpat, former director responsible for the operation of the company under the Securities Exchange Act B.E. 2535 (1992) and entrusted to manage the property of the
expense 3.81 0.69 3.12 453% Total cost of goods sold and expenses 341.39 311.69 29.71 10% The overview of cost of goods sold and expenses of the 3rd quarter of 2017, the company could manage cost of sales
Baht. However, the key criteria to acquire non-performing loan to manage is based on the yield of each portfolio in enhance a better return for the shareholders. Furthermore, with the strategy to expand
comparing the 6-month period of the year 2018 and 2019. In this regard, the cause of the decrease of revenue came from the domestic since the Company has the policy to manage the costs and expenses to be more
Company had the expenses for the feasibility study of some projects for the considering to investment of the management team. However, the financial cost has been increasing from the incremental issuance
Exchange of Thailand. The papers pointed out the significance of making prudent study on information and fundamental analysis of securities prior to making investment decision in order to mitigate trading
, 2019 was Baht 142.76 million increased by 52.90% from the same period of previous year amounted Baht 93.37 million. The increase in expense was mainly from feasibility study of new projects which will
control the system concentration limit not concise and does not manage the mutual fund management program as approved. SEC Act S.117 and 125(1) in conjunction with Section 90 of the Penal Code
and entrusted to manage company assets, in defrauding and embezzling SECC’s money. This case is in the process of inquiry by the special case prosecutor official. SEC Act S.315 Criminal Complaint